Plymouth Meeting, PA – March 17, 2016: CRF Health, the leading global provider of eCOA solutions for the life sciences industry, today announced its TrialMax® eCOA platform has been selected by a leading sponsor in the field of diabetes research. The solution will accelerate the collection of data through a third party medical device in support of a Phase III program of work encompassing multiple clinical trial protocols.
Furthering the company’s existing expertise in this therapeutic area, this latest program will see TrialMax used to capture more than 4.6 million data points via an integrated medical device. More than 3,000 patients across 450 sites in 28 countries will benefit from real-time integration of their diabetes care devices and patient diaries. Leveraging the solution will enable the program to be conducted faster by monitoring patients in real-time, while creating uniformity in reporting processes across the program’s individual studies.
CRF Health’s TrialMax Touch® handheld patient eDiary and TrialMax Slate® tablet solution will work together to bring increased insight into patient reported outcomes by delivering efficient and unobtrusive data collection. Using its collaborative design tool, TrialStudio®, CRF Health has worked in conjunction with the sponsor to create an innovative design which meets the specific protocol needs of diabetes and will enable its investigators to achieve more accurate and efficient data collection.
Commenting on the agreement, John Blakeley, Chief Business Officer at CRF Health, said: “Having collaborated previously to deliver numerous trials across multiple therapeutic areas, this latest program of work shows the confidence the sponsor has in our technology platform as well as our highly collaborative process to deliver results, and is evidence of the continued strength of our relationship. Our experience and proven track record in providing specific eCOA solutions for diabetes trials makes CRF Health ideally placed to deliver these important studies, and we are proud to have a part in developing better treatments for those living with this condition.”
For further information on CRF Health's eCOA platform for diabetes trials, please visit www.crfhealth.com.
About CRF Health
CRF Health is the leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. With experience in more than 650 trials, over 100 languages and across 74 countries, CRF Health’s TrialMax® eCOA solutions consistently demonstrate the industry’s highest data accuracy, patient and site compliance, and patient retention.
CRF Health’s TrialMax eCOA solutions improve trial engagement by fitting into the lives of patients and seamlessly integrating into sites to maximize protocol compliance. Their eCOA solutions include PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes) and ClinROs (Clinician or Rater Reported Outcomes).
Contact: email@example.com, +1 267.498.2350